We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
1926
Thermo Fisher Scientific
TMO
$220B
$39K ﹤0.01%
161
-8,789
-98% -$2.02M
WD icon
1927
Walker & Dunlop
WD
$1.53B
$39K ﹤0.01%
749
-2,665
-78% -$148K
VAR
1928
DELISTED
Varian Medical Systems, Inc.
VAR
$39K ﹤0.01%
352
-6,225
-95% -$704K
TGE
1929
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$39K ﹤0.01%
+1,657
New +$39.3K
SFS
1930
DELISTED
Smart & Final Stores, Inc.
SFS
$39K ﹤0.01%
6,709
+5,765
+611% +$36.3K
COWN
1931
DELISTED
Cowen Inc. Class A Common Stock
COWN
$39K ﹤0.01%
2,411
-2,088
-46% -$31.2K
LAB icon
1932
Standard BioTools
LAB
$314M
$38K ﹤0.01%
5,073
+940
+23% +$6.68K
MRSN
1933
DELISTED
Mersana Therapeutics
MRSN
$38K ﹤0.01%
151
+63
+72% +$21.1K
POR icon
1934
Portland General Electric
POR
$5.77B
$38K ﹤0.01%
832
+818
+5,843% +$37.2K
QGEN icon
1935
Qiagen
QGEN
$8.72B
$38K ﹤0.01%
952
-876
-48% -$35K
TV icon
1936
Televisa
TV
$1.49B
$38K ﹤0.01%
2,106
-1,391
-40% -$26.4K
ZBH icon
1937
Zimmer Biomet
ZBH
$18.4B
$38K ﹤0.01%
295
-4,607
-94% -$548K
JNCE
1938
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$38K ﹤0.01%
+5,748
New +$42.7K
KRA
1939
DELISTED
Kraton Corporation
KRA
$38K ﹤0.01%
812
-3,007
-79% -$143K
CORI
1940
DELISTED
Corium International, Inc.
CORI
$38K ﹤0.01%
4,023
+2,015
+100% +$17.4K
AVHI
1941
DELISTED
A V Homes, Inc.
AVHI
$38K ﹤0.01%
1,889
+454
+32% +$9.74K
CA
1942
DELISTED
CA, Inc.
CA
$38K ﹤0.01%
858
-14,484
-94% -$624K
AMD icon
1943
Advanced Micro Devices
AMD
$789B
$37K ﹤0.01%
+1,201
New +$27.1K
BBW icon
1944
Build-A-Bear
BBW
$462M
$37K ﹤0.01%
4,105
+158
+4% +$1.32K
BDC icon
1945
Belden
BDC
$5.19B
$37K ﹤0.01%
514
+226
+78% +$15.5K
BGSF icon
1946
BGSF Inc
BGSF
$60M
$37K ﹤0.01%
+1,378
New +$35.9K
CACC icon
1947
Credit Acceptance
CACC
$6.08B
$37K ﹤0.01%
85
+19
+29% +$7.97K
CUE icon
1948
Cue Biopharma
CUE
$114M
$37K ﹤0.01%
136
+125
+1,136% +$36.1K
DBEU icon
1949
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$799M
$37K ﹤0.01%
+1,300
New +$37.1K
FBIO icon
1950
Fortress Biotech
FBIO
$88.7M
$37K ﹤0.01%
+1,543
New +$49.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.6% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.